Doyle Mittie
Chief Medical Officer at AVTX
- Sold, on record
- $3M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Aug 28, 2026
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AVTXAvalo Therapeutics, Inc.Chief Medical Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AVTXRoutineJun 23, 2026 2026
Sold 1,450 shares at $18.00 ($26k)
Doyle Mittie, Chief Medical Officer
10b5-1 planSold 2.7% of holdings ($958k position)51,776 shares left0.4x usual sizeFollows a Form 144Filing
- 2 Form 4 sale AVTXRoutineJun 30, 2026 +7 days
Sold 4,654 shares at $20.00 ($93k)
Doyle Mittie, Chief Medical Officer
10b5-1 planSold 8.2% of holdings ($1.1M position)51,776 shares left1.6x usual sizeFollows a Form 144Filing
- 3 Form 4 sale AVTXRoutineJul 27, 2026 +27 days
Sold 1,000 shares at $20.00 ($20k)
Doyle Mittie, Chief Medical Officer
10b5-1 planSold 1.9% of holdings ($1.1M position)51,776 shares left0.3x usual sizeFollows a Form 144Filing
- 4 Form 144 notice AVTXNoticeAug 10, 2026 +14 days
Filed to sell 679 shares ($12k)
Doyle Mittie, Officer
10b5-1 plan0.2x usual sizeFiling
- 5 Form 4 sale AVTXRoutineAug 10, 2026 same day
Sold 679 shares at $20.00 ($14k)
Doyle Mittie, Chief Medical Officer
10b5-1 planSold 1.3% of holdings ($1M position)51,776 shares left0.2x usual sizeFollows a Form 144Filing
- 6 Form 144 notice AVTXNoticeAug 17, 2026 +7 days
Filed to sell 5,037 shares ($99k)
Doyle Mittie, Officer
10b5-1 plan2.3x usual sizeFiling
- 7 Form 4 sale AVTXRoutineAug 17, 2026 same day
Sold 1,000 shares at $20.00 ($20k)
Doyle Mittie, Chief Medical Officer
10b5-1 planSold 1.9% of holdings ($1.1M position)51,776 shares left0.4x usual sizeFollows a Form 144Filing
- 8 Form 4 sale AVTXRoutineAug 28, 2026 +11 days
Sold 679 shares at $20.00 ($14k)
Doyle Mittie, Chief Medical Officer
10b5-1 planSold 1.3% of holdings ($1M position)51,776 shares left0.5x usual sizeFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (17)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | Sep 1, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 679 | $14k | 1.3% | Routine | SEC |
| Aug 17, 2026 | Aug 19, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 1,000 | $20k | 1.9% | Routine | SEC |
| Aug 17, 2026 | Aug 17, 2026 | AVTX | Officer | Form 144 notice | 5,037 | $99k | Notice | SEC | |
| Aug 10, 2026 | Aug 12, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 679 | $14k | 1.3% | Routine | SEC |
| Aug 10, 2026 | Aug 10, 2026 | AVTX | Officer | Form 144 notice | 679 | $12k | Notice | SEC | |
| Jul 27, 2026 | Jul 29, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 1,000 | $20k | 1.9% | Routine | SEC |
| Jun 30, 2026 | Jul 2, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 4,654 | $93k | 8.2% | Routine | SEC |
| Jun 23, 2026 | Jun 25, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 1,450 | $26k | 2.7% | Routine | SEC |
| May 28, 2026 | Jun 1, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 679 | $11k | 1.4% | Routine | SEC |
| May 15, 2026 | May 19, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 3,000 | $56k | 45.3% | Routine | SEC |
| May 6, 2026 | May 7, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 108,234 | $2.2M | 96.8% | Unusual | SEC |
| May 6, 2026 | May 6, 2026 | AVTX | Officer | Form 144 notice | 54,508 | $886k | Notice | SEC | |
| Apr 6, 2026 | Apr 8, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 3,970 | $71k | 52.3% | Routine | SEC |
| Apr 6, 2026 | Apr 6, 2026 | AVTX | Officer | Form 144 notice | 65,800 | $1.2M | Notice | SEC | |
| Apr 1, 2026 | Apr 3, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 679 | $11k | 15.8% | Routine | SEC |
| Mar 16, 2026 | Mar 18, 2026 | AVTX | Chief Medical Officer | Form 4 sale | 25,492 | $412k | 87.6% | Routine | SEC |
| Mar 16, 2026 | Mar 16, 2026 | AVTX | Officer | Form 144 notice | 29,529 | $467k | Notice | SEC |